With the current healthcare system requiring more data, quality evidence, and proof of quality of care from manufacturers in increasing numbers, pharma companies are looking toward their medical affairs teams to effectively streamline the dissemination of medical information.
The role of the medical affairs group has grown steadily over recent years to include not only oversight of all scientific communications but product value marketing, publication planning, and dissemination of clinical trial data. Analysts have identified other areas of influence in which medical affairs professionals…
Around the Industry…
Melissa Hammond, Managing Director, Snowfish LLC
Debra Joyce, Senior VP, Managing Director, SCI Scientific Communications & Information, part of Ogilvy CommonHealth Worldwide
Robin Winter-Sperry, M.D., President and CEO, Scientific Advantage LLC